Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis

Reduction in tumor necrosis factor (αTNF) and interleukin-6 (IL-6) activities is a widely utilized strategy for the treatment of rheumatoid arthritis (RA) with a high success rate. Despite both schemes targeting the deprivation of inflammatory reactions caused by the excessive activity of cytokines,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stepanov, Alexander A., Malsagova, Kristina A., Kopylov, Arthur T., Rudnev, Vladimir R., Karateev, Dmitry E., Markelova, Evgenia I., Luchikhina, Elena L., Borisova, Elena E., Kaysheva, Anna L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964360/
https://www.ncbi.nlm.nih.gov/pubmed/36836953
http://dx.doi.org/10.3390/life13020596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964360/
https://www.ncbi.nlm.nih.gov/pubmed/36836953
http://dx.doi.org/10.3390/life13020596

Ejemplares similares